Insider Trading July 24, 2026 07:16 AM

Rhinebeck Bancorp Director Loughlin Acquires $149,120 in Stock Amid Structural Transition

Executive purchase follows shareholder approval for conversion to public holding company structure, with regulatory and capital raising milestones ahead.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
RBKB

Rhinebeck Bancorp, Inc. director Suzanne Loughlin completed a $149,120 share acquisition on July 22, 2026, purchasing 12,500 shares across two transactions priced between $11.92 and $11.93. The transaction occurs as the bank navigates a pivotal shift from a mutual holding company to a fully public structure, contingent on regulatory clearance and the successful placement of up to 8,912,500 new shares at $10.00 each.

Rhinebeck Bancorp Director Loughlin Acquires $149,120 in Stock Amid Structural Transition
RBKB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Insider accumulation by director Suzanne Loughlin, who purchased 12,500 shares totaling $149,120 on July 22, 2026, at prices between $11.92 and $11.93 per share.
  • Shareholder and depositor approval for conversion from mutual holding company to fully public stock holding company, contingent on regulatory approval and sale of at least 6,587,500 shares.
  • Launch of stock offering for up to 8,912,500 shares at $10.00 per share, targeting eligible depositors and employee benefit plans, with preference for New York county residents.

Suzanne Loughlin, a director at Rhinebeck Bancorp, Inc. (NASDAQ:RBKB), executed a significant share acquisition on July 22, 2026, totaling $149,120 in value. The director purchased 12,500 shares of the company's common stock through two distinct transactions. The acquisition price per share ranged from $11.92 to $11.93, reflecting the market conditions at the time of purchase.

This transaction is particularly notable given the recent performance of RBKB's stock, which has declined 27% over the past week. As of the reporting date, the stock was trading at $12.35. Market analysis tools indicate that RBKB is currently in oversold territory, with fair value assessments suggesting the stock may be undervalued at these current levels.

Key Points

  • Insider Accumulation: Following this acquisition, Ms. Loughlin directly holds 46,828 shares of Rhinebeck Bancorp common stock. This portfolio includes restricted stock that vests at a rate of 33 1/3% per year, commencing on May 26, 2027. Additionally, she holds 22,875 fully vested stock options with an exercise price of $4.70, which are set to expire on August 25, 2030.
  • Structural Transition: Rhinebeck Bancorp has announced that its stockholders and depositors have approved the conversion from a mutual holding company structure to a fully public stock holding company structure. This strategic move is contingent upon final regulatory approvals and the sale of at least 6,587,500 shares of common stock.
  • Capital Raising Initiative: Concurrently with the structural conversion, Rhinebeck Bancorp has launched a stock offering of up to 8,912,500 shares at $10.00 per share. The offering primarily targets eligible depositors and the bank's employee benefit plans. Unsubscribed shares may be made available to the general public, with preference given to residents of certain New York counties.

Risks and Uncertainties

  • Regulatory Dependency: The completion of the conversion from a mutual to a fully public structure is strictly contingent upon final regulatory approvals. Any delay or rejection in this process could impact the bank's strategic timeline and capital plans.
  • Capital Placement Risk: The success of the strategic transition relies heavily on the sale of at least 6,587,500 shares. Failure to meet this threshold could hinder the bank's ability to fully execute its public holding company structure.
  • Market Participation: The stock offering targets eligible depositors and employee benefit plans first, with public availability as a secondary step. Uncertainty remains regarding the level of interest from these groups and the broader public, particularly residents of certain New York counties who may receive preference.

To support the marketing of its common stock during this offering, Rhinebeck Bancorp has entered into an agreement with Keefe, Bruyette & Woods, Inc. (KBW). KBW will act as a financial advisor and marketing agent, receiving a management fee and a success fee based on the proceeds from the stock offering. These developments mark a critical phase in Rhinebeck Bancorp's evolution toward a fully public stock holding company.

Risks

  • Dependency on final regulatory approvals for the structural conversion from mutual to public holding company.
  • Requirement to sell at least 6,587,500 shares to complete the transition, posing execution risk if sales fall short.
  • Uncertainty surrounding capital placement in the stock offering, which prioritizes depositors and employee plans before public availability.

More from Insider Trading

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments Jul 24, 2026 Cytokinetics EVP Fady Malik Sells Stock Amid Myqorzo Launch Momentum Jul 24, 2026 Acrivon Therapeutics CLO Mary Miller Sells $1,008 in Company Stock Jul 24, 2026 Kaltura Officer Eynav Azaria Executes $8,971 Stock Sale Under Pre-Arranged Plan Jul 24, 2026 Travelers Executive Michael Klein Executes $2.2 Million Stock Disposition Amid Mixed Analyst Sentiment Jul 24, 2026